• Meet the DSRU team at ICPE Prague!

    The DSRU team will be attending the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) in Prague next week. Visit the DSRU Booth (#26) to find out about our capabilities: DSRU Consultancy ECHO – for observational studies on mental health products World-class PASS studies in primary and secondary care Listen to our oral presentations (see […]

    >Continue reading
  • Meet the DSRU’s new Principal Research Fellow, Dr Vicki Osborne

    We are pleased to announce that Dr Vicki Osborne is the DSRU’s new Principal Research Fellow. Vicki rejoins the DSRU after three years spent gaining her PhD in Epidemiology at the University of Florida. Vicki also has a Biomedical Science BSc from the University of Portsmouth and an Epidemiology MSc from the London School of […]

    >Continue reading
  • UK vote for continued involvement with EMA post-Brexit

    The DSRU welcomes the UK’s decision to have continued involvement in EU medicines regulation after Brexit. The UK Parliament voted last night for the UK to participate in the regulatory network operated by the European Medicines Agency (EMA) after it leaves the EU. The government confirmed that it would make an “appropriate financial contribution” in […]

    >Continue reading
  • DSRU registry expertise!

    Do you need a registry in order to fulfill your post-authorisation regulatory requirements? Look no further! We have been setting up and running registry studies for many years, including drug, disease and pregnancy registries. For further details click here or get in touch.

    >Continue reading
  • Don’t miss our Big Data for Pharmacovigilance conference!

    Our Big Data for Pharmacovigilance conference takes place in London on 20-21st June. With top-notch speakers from pharma, regulators and academia exploring Big Data from all angles, there will be something for everyone! There are a few places remaining, so book here now. Join the discussion on how Big Data should be harnessed by the […]

    >Continue reading